News | November 18, 2024
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Pablo Varas authored an article summarizing the 2024 ABA Antitrust Spring Meeting session on new frontiers in market definition. The panelists discussed recent healthcare merger enforcement actions and how companies are seeking to overcome those challenges. The panel discussed the role of market definition as a legal and economic tool in merger reviews and litigations and new tools and approaches to define markets in complex matters.
Read the article (membership may be required) here.